Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-29
2005-03-29
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
06872708
ABSTRACT:
A local injection prescription that disperses a malignant tumor to decrease the size of the tumor or terminate the tumor. The local injection prescription is produced by dissolving an organic compound having a lactone nucleus in lower alcohol and water.
REFERENCES:
patent: 5686274 (1997-11-01), Ali
patent: 6617304 (2003-09-01), Aoki et al.
patent: 6617314 (2003-09-01), Grosse-Bley et al.
patent: 6720302 (2004-04-01), Frerot et al.
patent: 6720327 (2004-04-01), Ruminski et al.
patent: 6746818 (2004-06-01), Kinsho et al.
patent: H5-7371 (1993-01-01), None
patent: WO9318652 (1993-09-01), None
patent: WO9318653 (1993-09-01), None
Patent Abstracts of Japan, Publication No. 04222595 A, Published Aug. 12, 1992.
Nishio et al., “Antitumor Effects of Butyrolactone I, a Selective cdc2 Kinase Inhibitor, on Human Lung Cancer Cell Lines,” (1996) Anticancer Research 16, pp. 3387-3388.
Mazurkiewicz, et al., “GABA Level and GAD Activity in Human and Mouse Normal and Neoplastic Mammary Gland,” (1999) J. Exp. Clin. Cancer Res., 18, 2, pp. 247-253.
Ishikawa Hisatake
Matsumoto Hirohiko
Matsumoto Mitsukazu
Beyer Weaver & Thomas LLP
Peselev Elli
LandOfFree
Local injection prescription does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Local injection prescription, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Local injection prescription will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3430723